{
  "id": 12949260,
  "title": "AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting",
  "url": "https://urgent.news/2026/10/08/abcellera-announces-presentation-of-phase-1-2-data-for-abcl635-at-tms",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-08T20:08:07.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/abcellera-announces-presentation-of-phase-1-2-data-for-abcl635-at-tms-2026-annual-meeting"
  },
  "original_language": "en",
  "account": null,
  "summary": "VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation of Phase 1/2 data on ABCL635 at The Menopause Society’s (TMS) 2026 Annual Meeting, to be held October 20 to 24 at the Hilton Bayfront in San Diego, California. Details on AbCellera’s poster presentation at TMS are as follows: Title: Safety, pharmacokinetics, […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual Meeting",
        "url": "https://urgent.news/2026/10/08/spruce-biosciences-announces-presentation-of-mps-iiib-natural-history",
        "published": "2026-10-08T20:08:48.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}